Meloxicam

Product NDC
71740-339
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Meloxicam
Dosage form
SUSPENSION
Route
ORAL
Labeler
Avondale Pharmaceuticals, LLC
Application
NDA021530
Marketing category
NDA
Substance
MELOXICAM
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
71740-339-111 BOTTLE, PLASTIC in 1 CARTON (71740-339-11) / 100 mL in 1 BOTTLE, PLASTIC20220621NoHistorical

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
4ddf5a4d-8e84-419d-8e3a-c91b85501885These highlights do not include all the information needed to use meloxicam oral suspension safely and effectively. See full prescribing information for meloxicam oral suspension. Meloxicam oral suspension Initial U.S. Approval: 2004Avondale Pharmaceuticals, LLC2024-01-24HUMAN PRESCRIPTION DRUG LABEL2